MCALLISTER & QUINN, LLC

Lobbying for AURAVAX THERAPEUTICS · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · Senate · posted Oct 20, 2025

Lobbying activity 3

Budget/Appropriations

Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Defense

Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Health Issues

Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.